Cargando…
Deferasirox: COVID-19 infection and asymptomatic COVID-19 reinfection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997478/ http://dx.doi.org/10.1007/s40278-021-93154-9 |
Ejemplares similares
-
Immunosuppressants: COVID-19 reinfection: case report
Publicado: (2021) -
Multiple drugs: Covid-19 reinfection: 2 case reports
Publicado: (2021) -
Ciclosporin/everolimus/rituximab: COVID-19, Epstein-Barr virus infection and COVID-19 reinfection: case report
Publicado: (2021) -
Multiple drugs: COVID-19 reinfection, COVID-19 reactivation and differentiation syndrome: case report
Publicado: (2021) -
Deferasirox: Duodenal perforation: case report
Publicado: (2021)